8-K: Microbot Medical Enters Phase 2 Collaboration with Corewell Health to Advance Remote Telesurgery

Microbot Medical has announced a Phase 2 collaboration with Corewell Health to further develop remote telesurgery capabilities using the LIBERTY Endovascular Robotic System.

Summary

• Microbot Medical has entered into a Phase 2 collaboration agreement with Corewell Health to advance remote telesurgery for endovascular procedures.
• This agreement follows the successful completion of Phase 1, which demonstrated the technical capabilities of the LIBERTY system.
• Phase 2 will focus on developing and demonstrating new telesurgery capabilities by performing simulated interventional procedures between two facilities within the Corewell Health system, which are five miles apart.
• The project will utilize the LIBERTY Endovascular Robotic System.
• The collaboration is led by Dr. Ryan Madder, Section Chief of Interventional Cardiology at Corewell Health.

Sentiment

Score: 7

Explanation: The announcement is positive, indicating progress in the development of the LIBERTY system and its potential for remote telesurgery. However, the document also acknowledges the inherent risks and uncertainties associated with the development and commercialization of medical devices.

Positives

• The Phase 2 collaboration agreement signifies continued progress in the development of the LIBERTY Endovascular Robotic System.
• The project aims to increase access to care for patients in remote locations.
• The successful completion of Phase 1 demonstrated the technical capabilities of the LIBERTY system.
• The collaboration with Corewell Health and Dr. Madder provides valuable expertise and resources.

Risks

• The development and commercialization of the LIBERTY system involves inherent risks.
• The outcome of studies to evaluate the LIBERTY system is uncertain.
• There are risks associated with pre-clinical and clinical trials, regulatory pathways, and approvals.
• The company may face challenges in recruiting physicians and clinicians for regulatory studies.
• Disruptions from geopolitical events and the COVID-19 pandemic could impact the company.
• The company needs to secure future capital and maintain intellectual property rights.

Future Outlook

The company aims to develop and demonstrate new telesurgery capabilities with the LIBERTY system, with the goal of increasing access to care for patients in remote locations. The company will continue to work with Corewell Health on this next phase of development.

Management Comments

• Harel Gadot, CEO, President and Chairman of Microbot Medical, stated that incorporating telesurgery capabilities is an important part of their long-term strategy for LIBERTY.
• Harel Gadot believes that physicians want to increase access to care for patients in remote locations.

Industry Context

This announcement aligns with the broader trend of increasing adoption of robotic surgery and telemedicine, particularly in specialized fields like endovascular procedures. The collaboration between a medical device company and a healthcare provider demonstrates a growing interest in remote surgical solutions.

Comparison to Industry Standards

• The development of remote telesurgery capabilities with the LIBERTY system positions Microbot Medical to compete with other companies in the robotic surgery space, such as Intuitive Surgical, Stryker, and Medtronic, who are also exploring robotic solutions for various surgical procedures.
• The focus on endovascular procedures is a niche area, and the LIBERTY system's miniaturized design and remote operation capabilities could differentiate it from larger, more cumbersome robotic systems.
• The collaboration with Corewell Health provides a real-world testing ground for the technology, which is crucial for demonstrating its clinical viability and potential for adoption.

Stakeholder Impact

• Shareholders may view this collaboration positively as it represents progress in the company's technology development.
• Physicians and clinicians may be interested in the potential of the LIBERTY system to improve access to care and reduce physician strain.
• Patients in remote locations may benefit from increased access to specialized endovascular procedures.

Next Steps

• Microbot Medical and Corewell Health will work together to develop the capabilities to perform simulated cardiovascular interventional procedures with the LIBERTY system.
• The project will involve testing the system across two sites within the Corewell Health system.

Key Dates

Keywords

remote telesurgery, endovascular procedures, robotic surgery, LIBERTY Endovascular Robotic System, Corewell Health, medical devices, interventional cardiology